Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway. - Zhou, Jie; Wang, Yanping; Zhu, Guangyan; Yan, Mingzhe; Li, Zhengnan; Li, Lin; Kuang, Jingwen; Zhang, Wenyuan; Huang, Chaolin; Ren, Fuli; Yang, Qingyu (Virology Journal, 2025)